The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ANAPLAN INC | COM | 03272L108 | 3,457 | 73,557 | SH | DFND | 0 | 73,557 | 0 | ||
AVALARA INC | COM | 05338G106 | 782 | 11,624 | SH | DFND | 0 | 11,624 | 0 | ||
CLOUDFLARE INC | CL A COM | 18915M107 | 132,134 | 7,115,467 | SH | DFND | 7,115,467 | 0 | 0 | ||
ELASTIC NV | ORD SHS | N14506104 | 495 | 6,012 | SH | DFND | 0 | 6,012 | 0 | ||
LYFT INC | CL A COM | 55087P104 | 32,045 | 784,649 | SH | DFND | 765,160 | 19,489 | 0 | ||
MOGU INC | SPON ADS | 608012100 | 4 | 1,482 | SH | DFND | 0 | 1,482 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 21,791 | 1,573,357 | SH | DFND | 1,573,357 | 0 | 0 | ||
PINDUODUO INC | SPONSORED ADS | 722304102 | 872 | 27,070 | SH | DFND | 0 | 27,070 | 0 | ||
SLACK TECHNOLOGIES INC | COM CL A | 83088V102 | 688 | 28,973 | SH | DFND | 0 | 28,973 | 0 | ||
SONOS INC | COM | 83570H108 | 23,706 | 1,767,826 | SH | DFND | 1,767,826 | 0 | 0 | ||
TENABLE HLDGS INC | COM | 88025T102 | 496 | 22,149 | SH | DFND | 0 | 22,149 | 0 | ||
THE REALREAL INC | COM | 88339P101 | 112,832 | 5,046,148 | SH | DFND | 5,046,148 | 0 | 0 | ||
UPWORK INC | COM | 91688F104 | 180 | 13,556 | SH | DFND | 0 | 13,556 | 0 | ||
VERACYTE INC | COM | 92337F107 | 160 | 6,652 | SH | DFND | 0 | 6,652 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 18 | 551 | SH | DFND | 0 | 551 | 0 |